What is Corstrata?
Headquartered in Savannah, Georgia, Corstrata is a provider of comprehensive wound care management programs. The company offers specialized services including wound patient consultations, wound program assessments, formulary design, treatment guideline evaluations, and wound documentation reviews. Corstrata aims to enhance patient outcomes and operational efficiency for healthcare providers through its expert-led wound care solutions. Its focus on detailed program assessment and education positions it as a key player in improving the standard of care for complex wounds.
How much funding has Corstrata raised?
Corstrata has raised a total of $24K across 1 funding round:
Debt
$24K
Debt (2021): $24K with participation from PPP
Key Investors in Corstrata
PPP
Public-Private Partnership
What's next for Corstrata?
Operating at a significant Series B/C stage, Corstrata is poised for substantial expansion. The recent influx of expansion capital is expected to fuel strategic initiatives, potentially including the scaling of its service offerings, geographic expansion, and further development of its technological infrastructure. This funding will likely enable Corstrata to deepen its market penetration and solidify its position as a leader in specialized wound care management, addressing the growing demand for effective chronic wound solutions.
See full Corstrata company page
